BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,937 | -7.6% | 26,624 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $87,593 | -37.6% | 26,624 | -39.7% | 0.01% | -14.3% |
| Q1 2023 | $140,314 | -54.0% | 44,124 | 0.0% | 0.01% | -62.2% |
| Q4 2022 | $305,338 | +9.3% | 44,124 | 0.0% | 0.04% | +15.6% |
| Q3 2022 | $279,305 | +13.5% | 44,124 | -25.9% | 0.03% | +52.4% |
| Q2 2022 | $246,000 | -64.0% | 59,524 | -57.7% | 0.02% | -27.6% |
| Q1 2022 | $683,000 | -54.7% | 140,824 | -6.6% | 0.03% | -68.5% |
| Q4 2021 | $1,507,000 | -65.7% | 150,824 | -34.5% | 0.09% | -67.3% |
| Q3 2021 | $4,397,000 | -36.1% | 230,100 | +7.0% | 0.28% | -34.3% |
| Q2 2021 | $6,876,000 | -4.2% | 215,000 | -9.7% | 0.43% | -5.7% |
| Q1 2021 | $7,176,000 | +2993.1% | 238,000 | +18207.7% | 0.45% | +1094.7% |
| Q4 2017 | $232,000 | – | 1,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |